HIV-1	Human Immunodeficiency Virus Type 1
ART	antiretroviral therapy
AIDS	Acquired Immunodeficiency Syndrome
CAR	Chimeric Antigen Receptor
LRAs	Latency-Reversing Agents
CRISPR	Clustered Regularly Interspaced Short Palindromic Repeats
bNAbs	Broadly Neutralizing Antibodies
LRA	Latency-Reversing Agent
CAR-T	Chimeric Antigen Receptor T
CCR5	C-C chemokine receptor type 5
CXCR4	C-X-C chemokine receptor type 4
RNA	Ribonucleic aciD
HMT	Histone MethylTransferase
BAF	Brahma-Related Gene 1/Brahma-associated factor
MLL1r	MLL1 rearrangement
mtNPM1	Mutant NPM1
MIs	Menin inhibitors
BET	Bromodomain and extra-terminal
TFs	Transcription Factors
LTRs	Long Terminal Repeats
PKC	Protein Kinase C
SMAC	Second Mitochondria-derived Activator of Caspases
NIK	NF-κB-Inducing Kinase
HDACi	Deacetylase inhibitors
ILs	Interleukins
TCRs	T cell receptors
TLR	Toll-like receptor
SIV	Simian Immunodeficiency Virus
SAHA	Suberoylanilide Hydroxamic Acid
BCL-2	B-cell Lymphoma 2
CTLs	Cytotoxic T Lymphocytes
CNS	Central Nervous System
SaCas9	Staphylococcus aureus Cas9
mTOR	mammalian Target of Rapamycin
sRNA	small RNA
sgRNA	single-guide RNA
TNFα	Tumor Necrosis Factor alpha
PAM	Protospacer Adjacent Motif
eSpCas9	enhanced specificity Cas9
nCas9	nicking Cas9
superFiCas9	Super Fidelity Cas9
IgG	Immunoglobulin G
DNA	Deoxyribonucleic acid